ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

Nimotuzumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma (NPC): A prospective, randomized-controlled, double-blinded, multicenter phase III clinical trial.

Sun, Yan; Hu, Chaosu; Lin, Qin; Gao, Li; Wang, Jianhua; Zhu, Xiaodong; Hao, Junfang; Lang, Jin Yi; Wang, Peiguo; Ye, Ming; Li, Xia; Xu, Benhua; Wu, Rong; Bai, Chunmei; You, Qingshan; Chen, Xiaozhong; Wang, Jun; Hu, Desheng; Wu, Gang; Pan, Jian-Ji电子科技大学; 复旦大学; 华中科技大学; 上海交通大学; 哈尔滨医科大学; 河北医科大学; 郑州大学; 厦门大学; 中国医科大学; 中国医学科学院; 中国科学院研究生院; 中国医学科学院北京协和医院; 1
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)2022-6-1
4被引8阅读
引用收藏
分享
相关
加载中…
  • Nimotuzumab combined with concurrent chemo-radiotherapy in patients with locally advanced cervical squamous cell carcinoma: A randomized, controlled, open-label, multicenter study
    Wang, J.; Jiang, P.; Wei, L.; Zou, L.; Li, X.; Wang, C.; Sun, X.; Ding, L.; Yuan, X.; Cheng, H.; Wu, D.; Cai, R.; Yin, R.; Zhang, J.; Qiu, H.; Wang, T.; Gao, K.; Zhuo, Y.; Zhang, Y.; Zhao, F.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 2023-10-20 To 2023-10-24.
  • Induction chemotherapy plus radiotherapy alone versus cisplatin-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: An open-label, non-inferiority, randomized phase 3 trial.
    Chen, MingYuan; Huang, Peiyu; Chen, Xuyin; Ding, Xi; Ling, Guo; Mo, Hao-Yuan; Duan, Chongyang; Ling, Li; Zou, Xiong; Liu, You-Ping; You, Rui; Xie, Yulong; Cao, Jingyu; Liu, Sihan; Wang, Zimeng; Yang, Qi; Qiu, Fang; Hua, Yijun; Cao, Kajia; Luo, Dong-HuaAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
  • Nab-paclitaxel plus cisplatin versus docetaxel plus cisplatin and 5-FU induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: A multicenter parallel controlled phase III trial.
    Lv, Xing; Zeng, Qi; Zhang, Weijun; Cheng, Hao; Xia, Weixiong; Yanqun, Xiang; Liang, Hu; Cao, Xun; Chen, Xi; Zhan, Zejiang; Deng, Ying; Zhou, Jiayu; Zhang, Lulu; Liang, Chixiong; Huang, Haoyang; Huang, Yingying; Cai, Zhuocheng; Guo, XiangAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
查看全部 →

会议信息

会议名称
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
会议日期
2022-06-03 至 2022-06-07
论文集名
JOURNAL OF CLINICAL ONCOLOGY
发表日期
2022-06-01
收录
ISTP · SCIE

作者

  • S

    Sun, Yan (第一作者)

  • H

    Hu, Chaosu

查看全部 20 位作者收起作者
  • L

    Lin, Qin

  • G

    Gao, Li

  • W

    Wang, Jianhua

  • Z

    Zhu, Xiaodong

  • H

    Hao, Junfang

  • L

    Lang, Jin Yi

  • W

    Wang, Peiguo

  • Y

    Ye, Ming

  • L

    Li, Xia

  • X

    Xu, Benhua

  • W

    Wu, Rong

  • B

    Bai, Chunmei

  • Y

    You, Qingshan

  • C

    Chen, Xiaozhong

  • W

    Wang, Jun

  • H

    Hu, Desheng

  • W

    Wu, Gang

  • P

    Pan, Jian-Ji

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417